Start > Research > List of Publications > List of publications 2012

List of publications 2012

  1. Acharya G, Albrecht C, Benton SJ, Cotechini T, Dechend R, Dilworth MR, Duttaroy AK, Grotmol T, Heazell AE, Jansson T, Johnstone ED, Jones HN, Jones RL, Lager S, Laine K, Nagirnaja L, Nystad M, Powell T, Redman C, Sadovsky Y, Sibley C, Troisi R, Wadsack C, Westwood M, Lash GE. IFPA meeting 2011 workshop report I: Placenta: Predicting future health; roles of lipids in the growth and development of feto-placental unit; placental nutrient sensing; placental research to solve clinical problems - A translational approach. Placenta 2012; 33(Suppl.):S4-S8.
    http://www.placentajournal.org/article/S0143-4004(11)00547-9/abstract
  2. Andersson K, Michael KM, Luostarinen T, Waterboer T, Gislefoss R, Hakulinen T, Forslund O, Pawlita M, Dillner J. Prospective Study of Human Papillomavirus Seropositivity and Risk of Nonmelanoma Skin Cancer. Am J Epidemiol 2012; 175(7):685-695.
    http://www.ncbi.nlm.nih.gov/pubmed/22419740?dopt=Citation
  3. Arbyn M, Weiderpass E, Capocaccia R. Effect of screening on deaths from cervical cancer in Sweden. BMJ 2012; 344(7849):e804.
    http://www.ncbi.nlm.nih.gov/pubmed/22381675?dopt=Citation
  4. Baste V, Moen BE, Oftedal G, Strand LA, Bjorge L, Mild KH. Pregnancy Outcomes After Paternal Radiofrequency Field Exposure Aboard Fast Patrol Boats. J Occup Environ Med 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22354128?dopt=Citation
  5. Borena W, Strohmaier S, Lukanova A, Bjorge T, Lindkvist B, Hallmans G, Edlinger M, Stocks T, Nagel G, Manjer J, Engeland A, Selmer R, Haggstrom C, Tretli S, Concin H, Jonsson H, Stattin P, Ulmer H. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. Int J Cancer 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/21805476?dopt=Citation
  6. Brelin S, Loge JH, Skurtveit S, Johannesen TB, Aass N, Ottesen S, Hjermstad MJ. Antidepressants to cancer patients during the last year of life-a population-based study. Psychooncology 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22392773?dopt=Citation
  7. Brenner H, Bouvier AM, Foschi R, Hackl M, Larsen IK, Lemmens V, Mangone L, Francisci S. Progress in colorectal cancer survival in Europe, from the late 1980s to the early 21st century: The EUROCARE study. Int J Cancer 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/21607946?dopt=Citation
  8. Canchola AJ, Anton-Culver H, Bernstein L, Clarke CA, Henderson K, Ma H, Ursin G, Horn-Ross PL. Body size and the risk of postmenopausal breast cancer subtypes in the California Teachers Study cohort. Cancer Causes Control 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22286371?dopt=Citation
  9. Chuang SC, Jenab M, Heck JE, Bosetti C, Talamini R, Matsuo K, Castellsague X, Franceschi S, Herrero R, Winn DM, La VC, Morgenstern H, Zhang ZF, Levi F, Dal ML, Kelsey K, McClean MD, Vaughan T, Lazarus P, Muscat J, Ramroth H, Chen C, Schwartz SM, Eluf-Neto J, Hayes RB, Purdue M, Boccia S, Cadoni G, Zaridze D, Koifman S, Curado MP, Ahrens W, Benhamou S, Matos E, Lagiou P, Szeszenia-Dabrowska N, Olshan AF, Fernandez L, Menezes A, Agudo A, Daudt AW, Merletti F, Macfarlane GJ, Kjaerheim K, Mates D, Holcatova I, Schantz S, Yu GP, Simonato L, Brenner H et al. Diet and the risk of head and neck cancer: a pooled analysis in the INHANCE consortium. Cancer Causes Control 2012; 23(1):69-88.
    http://www.ncbi.nlm.nih.gov/pubmed/22037906?dopt=Citation
  10. Couto E, Qureshi SA, Hofvind S, Hilsen M, Aase H, Skaane P, Vatten L, Ursin G. Hormone therapy use and mammographic density in postmenopausal Norwegian women. Breast Cancer Res Treat 2012; 132(1):297-305.
    http://www.ncbi.nlm.nih.gov/pubmed/22052325?dopt=Citation
  11. Deltour I, Auvinen A, Feychting M, Johansen C, Klaeboe L, Sankila R, Schuz J. Mobile Phone Use and Incidence of Glioma in the Nordic Countries 1979-2008: Consistency Check. Epidemiology 2012; 23(2):301-307.
    http://www.ncbi.nlm.nih.gov/pubmed/22249239?dopt=Citation
  12. Duan L, Xu X, Koebnick C, Lacey JV, Jr., Sullivan-Halley J, Templeman C, Marshall SF, Neuhausen SL, Ursin G, Bernstein L, Henderson KD. Bilateral oophorectomy is not associated with increased mortality: the California Teachers Study. Fertil Steril 2012; 97(1):111-117.
    http://www.ncbi.nlm.nih.gov/pubmed/22088205?dopt=Citation
  13. Edlinger M, Strohmaier S, Jonsson H, Bjorge T, Manjer J, Borena WT, Haggstrom C, Engeland A, Tretli S, Concin H, Nagel G, Selmer R, Johansen D, Stocks T, Hallmans G, Stattin P, Ulmer H. Blood pressure and other metabolic syndrome factors and risk of brain tumour in the large population-based Me-Can cohort study. J Hypertens 2012; 30(2):290-296.
    http://www.ncbi.nlm.nih.gov/pubmed/22179083?dopt=Citation
  14. Enerly E, Bray F, Mellem C, Hansen BT, Kjolberg G, Dahl T, Johannesen TB, Nygard M. Quality assessment of the registration of vulvar and vaginal premalignant lesions at the Cancer Registry of Norway. Acta Oncol 2012; 51(1):45-50.
    http://www.ncbi.nlm.nih.gov/pubmed/22047060?dopt=Citation
  15. Garwicz S, Anderson H, Olsen JH, Falck WJ, Sankila R, Langmark F, Tryggvadottir L, Moller TR. Late and very late mortality in 5-year survivors of childhood cancer: Changing pattern over four decades. Experience from the Nordic countries. Int J Cancer 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22170520?dopt=Citation
  16. Grimsrud TK, Andersen A. Unrecognized risks of nickel-related respiratory cancer among Canadian electrolysis workers. Scand J Work Environ Health 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22258056?dopt=Citation
  17. Gulati S, Jakola AS, Johannesen TB, Solheim O. Survival and Treatment Patterns of Glioblastoma in the Elderly: A Population-based Study. World Neurosurg 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22381305?dopt=Citation
  18. Hauge IH, Pedersen K, Sanderud A, Hofvind S, Olerud HM. Patient doses from screen-film and full-film digital mammography in a populatian based screening-program. Radiat Prot Dosimetry 2012; 148(1):65-73.
    http://www.ncbi.nlm.nih.gov/pubmed/21335333?dopt=Citation
  19. Hoff G, Moritz V, Bretthauer M, Aabakken L, Berset IP, Glomsaker T, Hoie O, de LT. Incontinence after colonoscopy - an unrecognized and preventable problem. A cross-sectional study from the Gastronet quality assurance program. Endoscopy 2012; 44(4):349-353.
    http://www.ncbi.nlm.nih.gov/pubmed/22392101?dopt=Citation
  20. Hofvind S, Sakshaug S, Ursin G, Graff-Iversen S. Breast cancer incidence trends in Norway - explained by hormone therapy or mammographic screening? Int J Cancer 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/21732346?dopt=Citation
  21. Hofvind S, Skaane P. Stage Distribution of Breast Cancer Diagnosed Before and After Implementation of Population-Based Mammographic Screening. Rofo 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22426937?dopt=Citation
  22. Holmberg L, Robinson D, Sandin F, Bray F, Linklater KM, Klint A, Lambert PC, Adolfsson J, Hamdy FC, Catto J, Moller H. A comparison of prostate cancer survival in England, Norway and Sweden: A population-based study. Cancer Epidemiol 2012; 36(1):e7-12.
    http://www.ncbi.nlm.nih.gov/pubmed/21907655?dopt=Citation
  23. Hustad S, Eussen S, Midttun O, Ulvik A, van de Kant PM, Morkrid L, Gislefoss R, Ueland PM. Kinetic modeling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism. Clin Chem 2012; 58(2):402-410.
    http://www.ncbi.nlm.nih.gov/pubmed/22194632?dopt=Citation
  24. Koivisto-Korander R, Scelo G, Ferro G, Mellemkjaer L, Hemminki K, Weiderpass E, Tamaro S, Pompe-Kirn V, Tracey E, Brewster DH, Kliewer EV, Tonita JM, Kee-Seng C, Jonasson JG, Martos C, Brennan P, Straif K, Pukkala E. Second primary malignancies among women with uterine sarcoma. Gynecol Oncol 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22487538?dopt=Citation
  25. Koivisto-Korander R, Martinsen JI, Weiderpass E, Leminen A, Pukkala E. Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: Results from NORDCAN and NOCCA databases. Maturitas 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22377186?dopt=Citation
  26. Kristiansen W, Andreassen KE, Karlsson R, Aschim EL, Bremnes RM, Dahl O, Fossa SD, Klepp O, Langberg CW, Solberg A, Tretli S, Adami HO, Wiklund F, Grotmol T, Haugen TB. Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population. Hum Reprod 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22402210?dopt=Citation
  27. Kvammen O, Tretli S, Johannessen TB, Klepp O, Grotmol T. Testicular cancer risk according to county of birth and county of diagnosis in Norway, 1958-2007. Acta Oncol 2012; 51(2):177-184.
    http://www.ncbi.nlm.nih.gov/pubmed/22248063?dopt=Citation
  28. Langseth H, Gislefoss R, Martinsen JI, Tretli S. Scientific scope of integrating research activities in the Janus Serum Bank. Nor J Epidemiol 2012; 21(2):185-190.
    http://www.ntnu.no/ojs/index.php/norepid
  29. Lee E, Ingles SA, Van Den Berg D, Wang W, Lavallee C, Huang MH, Crandall CJ, Stanczyk FZ, Greendale GA, Ursin G. Progestogen levels, progesterone receptor gene polymorphisms, and mammographic density changes: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study. Menopause 2012; 19(3):302-310.
    http://www.ncbi.nlm.nih.gov/pubmed/22105149?dopt=Citation
  30. Lee E, Hsu C, Van Den Berg D, Ursin G, Koh WP, Yuan JM, Stram DO, Yu MC, Wu AH. Genetic variation in peroxisome proliferator-activated receptor gamma, soy, and mammographic density in Singapore Chinese women. Cancer Epidemiol Biomarkers Prev 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22301832?dopt=Citation
  31. Macfarlane TV, Macfarlane GJ, Thakker NS, Benhamou S, Bouchardy C, Ahrens W, Pohlabeln H, Lagiou P, Lagiou A, Castellsague X, Agudo A, Slamova A, Plzak J, Merletti F, Richiardi L, Talamini R, Barzan L, Kjaerheim K, Canova C, Simonato L, Conway DI, McKinney PA, Thomson P, Sloan P, Znaor A, Healy CM, McCartan BE, Marron M, Brennan P. Role of medical history and medication use in the aetiology of upper aerodigestive tract cancers in Europe: the ARCAGE study. Ann Oncol 2012; 23(4):1053-1060.
    http://www.ncbi.nlm.nih.gov/pubmed/21828376?dopt=Abstract
  32. Mahabir S, Aagaard K, Anderson LM, Herceg Z, Hiatt RA, Hoover RN, Linet MS, Medina D, Potischman N, Tretli S, Trichopoulos D, Troisi R. Challenges and opportunities in research on early-life events/exposures and cancer development later in life. Cancer Causes Control 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22527169?dopt=Citation
  33. Marchbanks PA, Curtis KM, Mandel MG, Wilson HG, Jeng G, Folger SG, McDonald JA, Daling JR, Bernstein L, Malone KE, Wingo PA, Simon MS, Norman SA, Strom BL, Ursin G, Weiss LK, Burkman RT, Spirtas R. Oral contraceptive formulation and risk of breast cancer. Contraception 2012; 85(4):342-350.
    http://www.ncbi.nlm.nih.gov/pubmed/22067757?dopt=Citation
  34. Moritz V, Bretthauer M, Ruud HK, Glomsaker T, de LT, Sandvei P, Huppertz-Hauss G, Kjellevold O, Hoff G. Withdrawal time as a quality indicator for colonoscopy - a nationwide analysis. Endoscopy 2012; 44(5):476-481.
    http://www.ncbi.nlm.nih.gov/pubmed/22531983?dopt=Citation
  35. Nagel G, Bjorge T, Stocks T, Manjer J, Hallmans G, Edlinger M, Haggstrom C, Engeland A, Johansen D, Kleiner A, Selmer R, Ulmer H, Tretli S, Jonsson H, Concin H, Stattin P, Lukanova A. Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can). Br J Dermatol 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22530854?dopt=Citation
  36. Nygard M, Aagnes B, Bray F, Moller B, Mork J. Population-based evidence of increased survival in human papillomavirus-related head and neck cancer. Eur J Cancer 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22516210?dopt=Citation
  37. Olesen TB, Jensen KE, Nygard M, Tryggvadottir L, Sparen P, Hansen BT, Liaw KL, Kjaer SK. Young age at first intercourse and risk-taking behaviours--a study of nearly 65 000 women in four Nordic countries. Eur J Public Health 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/21596800?dopt=Citation
  38. Pukkala E, Helminen M, Haldorsen T, Hammar N, Kojo K, Linnersjo A, Rafnsson V, Tulinius H, Tveten U, Auvinen A. Cancer incidence among Nordic airline cabin crew. Int J Cancer 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22447246?dopt=Citation
  39. Qureshi SA, Couto E, Hofvind S, Wu AH, Ursin G. Alcohol intake and mammographic density in postmenopausal Norwegian women. Breast Cancer Res Treat 2012; 131(3):993-1002.
    http://www.ncbi.nlm.nih.gov/pubmed/21993860?dopt=Citation
  40. Razavi P, Lee E, Bernstein L, Van Den Berg D, Horn-Ross PL, Ursin G. Variations in sex hormone metabolism genes, postmenopausal hormone therapy, and risk of endometrial cancer. Int J Cancer 2012; 130(7):1629-1638.
    http://www.ncbi.nlm.nih.gov/pubmed/21544810?dopt=Citation
  41. Richiardi L, Corbin M, Marron M, Ahrens W, Pohlabeln H, Lagiou P, Minaki P, Agudo A, Castellsague X, Slamova A, Schejbalova M, Kjaerheim K, Barzan L, Talamini R, Macfarlane GJ, Macfarlane TV, Canova C, Simonato L, Conway DI, McKinney A, Sneddon L, Thomson P, Znoar A, Healy CM, McCartan BE, Benhamou S, Bouchardy C, Hashibe M, Brennan P, Merletti F. Occupation and risk of upper aerodigestive tract cancer: The ARCAGE study. Int J Cancer 2012; 130(10):2397-404.
    http://www.ncbi.nlm.nih.gov/pubmed/21671472
  42. Rinaldi S, Lise M, Clavel-Chapelon F, Boutron-Ruault MC, Guillas G, Overvad K, Tjonneland A, Halkjaer J, Lukanova A, Kaaks R, Bergmann MM, Boeing H, Trichopoulou A, Zylis D, Valanou E, Palli D, Agnoli C, Tumino R, Polidoro S, Mattiello A, Bas Bueno-de-Mesquita H, Peeters PH, Weiderpass E, Lund E, Skeie G, Rodriguez L, Travier N, Sanchez MJ, Amiano P, Huerta JM, Ardanaz E, Rasmuson T, Hallmans G, Almquist M, Manjer J, Tsilidis KK, Allen NE, Khaw KT, Wareham N, Byrnes G, Romieu I, Riboli E, Franceschi S. Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study. Int J Cancer 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22511178?dopt=Citation
  43. Riska A, Martinsen JI, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Weiderpass E, Pukkala E. Occupation and risk of primary fallopian tube carcinoma in nordic countries. Int J Cancer 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/21805475?dopt=Citation
  44. Rogne SG, Ronning P, Helseth E, Johannesen TB, Langberg CW, Lote K, Scheie D, Meling TR. Craniotomy for brain metastases: a consecutive series of 316 patients. Acta Neurol Scand 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/21902675?dopt=Citation
  45. Sagerup CM, Smastuen M, Johannesen TB, Helland A, Brustugun OT. Increasing Age and Carcinoma Not Otherwise Specified: A 20-Year Population Study of 40,118 Lung Cancer Patients. J Thorac Oncol 2012; 7(1):57-60.
    http://www.ncbi.nlm.nih.gov/pubmed/21900838?dopt=Citation
  46. Sant M, Minicozzi P, Lagorio S, Johannesen TB, Marcos-Gragera R, Francisci S. Survival of european patients with central nervous system tumors. Int J Cancer 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/21805473?dopt=Citation
  47. Skaane P, Kshirsagar A, Hofvind S, Jahr G, Castellino RA. Mammography screening using independent double reading with consensus: Is there a potential benefit for computer-aided detection? Acta Radiol 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22287148?dopt=Citation
  48. Solheim O, Jakola AS, Gulati S, Johannesen TB. Incidence and causes of perioperative mortality after primary surgery for intracranial tumors: a national, population-based study. J Neurosurg 2012; 116(4):825-834.
    http://www.ncbi.nlm.nih.gov/pubmed/22224790?dopt=Citation
  49. Stang A, Martinsen JI, Kjaerheim K, Weiderpass E, Sparen P, Tryggvadottir L, Pukkala E. Cancer incidence among priests: 45 years of follow-up in four Nordic countries. Eur J Epidemiol 2012; 27(2):101-8.
    http://www.ncbi.nlm.nih.gov/pubmed/22200870?dopt=Citation
  50. Stensvold A, Dahl AA, Brennhovd B, Cvancarova M, Fossa SD, Lilleby W, Axcrona K, Smeland S. Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormones. Prostate 2012; 72(6):668-76.
    http://www.ncbi.nlm.nih.gov/pubmed/21809351?dopt=Citation
  51. Stensvold A, Dahl AA, Brennhovd B, Smastuen MC, Fossa SD, Lilleby W, Steinsvik A, Axcrona K, Smeland S. Bother problems in prostate cancer patients after curative treatment. Urol Oncol 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22341412?dopt=Citation
  52. Stocks T, Van HM, Manjer J, Bjorge T, Ulmer H, Hallmans G, Lindkvist B, Selmer R, Nagel G, Tretli S, Concin H, Engeland A, Jonsson H, Stattin P. Blood Pressure and Risk of Cancer Incidence and Mortality in the Metabolic Syndrome and Cancer Project. Hypertension 2012; 59(4):802-10.
    http://www.ncbi.nlm.nih.gov/pubmed/22353615?dopt=Citation
  53. Strand TE, Bartnes K, Rostad H. National trends in lung cancer surgery. Eur J Cardiothorac Surg 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22402451?dopt=Citation
  54. Syse A, Lyngstad TH, Kravdal O. Does mortality after childhood cancer depend upon parents' social or economic resources? A population-based study. Int J Cancer 2012; 130(8):1870-1878.
    http://www.ncbi.nlm.nih.gov/pubmed/21618515?dopt=Citation
  55. Syse A, Aas GB, Loge JH. Children and young adults with parents with cancer: a population-based study. Clin Epidemiol 2012; 4(1):41-52.
    http://www.ncbi.nlm.nih.gov/pubmed/22442635?dopt=Citation
  56. Syse A, Tonnessen M. Cancer's unequal impact on incomes in Norway. Acta Oncol 2012; 51(4):480-489.
    http://www.ncbi.nlm.nih.gov/pubmed/22150076?dopt=Citation
  57. Trama A, Mallone S, Nicolai N, Necchi A, Schaapveld M, Gietema J, Znaor A, Ardanaz E, Berrino F. Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe. Eur J Cancer 2012; 48(2):159-169. Samarbeid: Ursin, G
    http://www.ncbi.nlm.nih.gov/pubmed/22142457?dopt=Citation
  58. Tretli S, Schwartz GG, Torjesen PA, Robsahm TE. Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control 2012; 23(2):363-370.
    http://www.ncbi.nlm.nih.gov/pubmed/22193397?dopt=Citation
  59. Trope A, Sjoborg KD, Nygard M, Roysland K, Campbell S, Alfsen GC, Jonassen CM. Cytology and HPV testing 6-12 months after ASCUS/LSIL cytology in organised screening to predict high-grade cervical neoplasia between screening rounds. J Clin Microbiol 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22518869?dopt=Citation
  60. Tukenova M, Diallo I, Anderson H, Hawkins M, Garwicz S, Sankila R, El FC, Winter D, Rubino C, Adjadj E, Haddy N, Oberlin O, Moller T, Langmark F, Tryggvadottir L, Pacquement H, Svahn-Tapper G, de VF. Second malignant neoplasms in digestive organs after childhood cancer: a cohort-nested case-control study. Int J Radiat Oncol Biol Phys 2012; 82(3):e383-e390.
    http://www.ncbi.nlm.nih.gov/pubmed/22284034?dopt=Citation
  61. Ulmer H, Bjorge T, Concin H, Lukanova A, Manjer J, Hallmans G, Borena W, Haggstrom C, Engeland A, Almquist M, Jonsson H, Selmer R, Stattin P, Tretli S, Kleiner A, Stocks T, Nagel G. Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can). Gynecol Oncol 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22330614?dopt=Citation
  62. Vachon CM, Scott CG, Fasching PA, Hall P, Tamimi RM, Li J, Stone J, Apicella C, Odefrey F, Gierach GL, Jud SM, Heusinger K, Beckmann MW, Pollan M, Fernandez-Navarro P, Gonzalez-Neira A, Benitez J, van Gils CH, Lokate MA, Onland-Moret NC, Peeters PH, Brown J, Leyland J, Varghese JS, Easton DF, Thompson DJ, Luben RN, Warren RM, Wareham NJ, Loos RJ, Khaw KT, Ursin G, Lee E, Gayther SA, Ramus SJ, Eeles RA, Leach MO, Kwan-Lim For The Uk Study Of Mri Screening, Couch FJ, Giles GG, Baglietto L, Krishnan K, Southey MC, Le ML, Kolonel LN, Woolcott C, Maskarinec G, Haiman CA, Walker K, Johnson N et al. Common Breast Cancer Susceptibility Variants in LSP1 and RAD51L1 Are Associated with Mammographic Density Measures that Predict Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22454379?dopt=Citation
  63. van GW, van den Broek CB, Mroczkowski P, Dziki A, Romano G, Pavalkis D, Wouters MW, Moller B, Wibe A, Pahlman L, Harling H, Smith JJ, Penninckx F, Ortiz H, Valentini V, van de Velde CJ. The EURECCA project: Data items scored by European colorectal cancer audit registries. Eur J Surg Oncol 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22285051?dopt=Citation
  64. Weedon-Fekjaer H, Bakken K, Vatten LJ, Tretli S. Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use. BMJ 2012; 344(7845):e299.
    http://www.ncbi.nlm.nih.gov/pubmed/22290099?dopt=Citation
  65. Weiderpass E, Sandin S, Inoue M, Shimazu T, Iwasaki M, Sasazuki S, Sawada N, Yamaji T, Tsugane S. Risk factors for epithelial ovarian cancer in Japan - results from the Japan Public Health Center-based Prospective Study cohort. Int J Oncol 2012; 40(1):21-30.
    http://www.ncbi.nlm.nih.gov/pubmed/21904774?dopt=Citation
  66. Woolcott CG, Koga K, Conroy SM, Byrne C, Nagata C, Ursin G, Vachon CM, Yaffe MJ, Pagano I, Maskarinec G. Mammographic density, parity and age at first birth, and risk of breast cancer: an analysis of four case-control studies. Breast Cancer Res Treat 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22222356?dopt=Citation
  67. Zhang X, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Gapstur SM, Giles GG, Giovannucci E, Goodman G, Hankinson SE, Helzlsouer KJ, Horn-Ross PL, Inoue M, Jung S, Khudyakov P, Larsson SC, Lof M, McCullough ML, Miller AB, Neuhouser ML, Palmer JR, Park Y, Robien K, Rohan TE, Ross JA, Schouten LJ, Shikany JM, Tsugane S, Visvanathan K, Weiderpass E, Wolk A, Willett WC, Zhang SM, Ziegler RG, Smith-Warner SA. Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies. Am J Clin Nutr 2012; 95(3):713-25.
    http://www.ncbi.nlm.nih.gov/pubmed/22277553?dopt=Citation
Page was last edited 4/26/2012 3:49:52 PM by sos